Paper Details

Paper Title

Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma.

Paper Journal Title

J Proteome Res

Paper Citation Count

Paper Publication Year

2019

Bio Mention

ABC, ABC DLBCL, ABC and GCB DLBCL cell lines, Activated B-Cell Subtype, Aurora kinases, B-, CDK4, CDK6, DLBCL, Dasatinib, Diffuse Large B-Cell Lymphoma, Diffuse large B-cell lymphoma, GCB, NF-B, Patients, SFK, SFKs, Src family kinase, activated B, activated B-cell, dasatinib, germinal center B-, germinal center B-cell (GCB) DLBCL, patients

Mesh Descriptor

Paper Details

Column Actions

Datasets